Related Experiment Video

Updated: Aug 24, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Reply to Salkeld et al.: Diversity-disease patterns are robust to study design, selection criteria, and publication

David J Civitello1, Jeremy Cohen2, Hiba Fatima3

  • 1Department of Integrative Biology, University of South Florida, Tampa, FL 33620; civitello@usf.edu.

Proceedings of the National Academy of Sciences of the United States of America
|October 29, 2015
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Comparative Lesions Analysis Through a Targeted Sequencing Approach08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Multi-Locus Sequencing for Strain Typing of Toxoplasma gondii11:09

Multi-Locus Sequencing for Strain Typing of Toxoplasma gondii

Published on: May 26, 2026

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...